News for Shilpa Medicare Limited (SHILPAMED.NS)

PR NewswireRAICHUR, India, March 12, 2025 RAICHUR, India , March 12, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading

RAICHUR, India , March 12, 2025 /PRNewswire/ -- Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug (IND) - Nor Ursodeoxycholic Acid (Nor UDCA) Tablets 500 mg - and recommended marketing authorization for treating non-alcoholic fatty liver disease (NAFLD).

Shilpa Medicare Limited's Telangana facilities receive EAEU GMP certification, boosting shares on NSE; expanding business in member countries.

Indian indices hit new record highs for the third straight session, boosted by the US Fed's rate cut. Analysts remain positive on the market's outlook, with Nifty expected to rise towards 26,200. Support is at 25,700.

Tech Mahindra, Wipro, Infosys, LTIMindtree and TCS were among the top losers on NSE.

Jul 08, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good day, and welcome to Shilpa Medicare Limited business update call. (Operator Instructions) Please n

RAICHUR, India, Aug. 28, 2024 /PRNewswire/ -- In a major breakthrough, Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship product, sRbumin® - recombinant human albumin® 20% (rHA), becoming the first Indian company to achieve this milestone. The positive results underscore rHA's potential as a viable alternative to plasma-derived human serum albumin, addressing a critical gap in global healthcare.

Shilpa Medicare Share Price: Northward surge in the stock price is attributed to the news that the company has received approval from the US Food and Drug Administration (USFDA) for its product, 'Bortezomib Injection NDA 212782

Shilpa Medicare, held by Madhusudhan Kela and Sunil Singhania, has returned 45% since its QIP allotment four months ago. Singhania's Abakkus Diversified Alpha Fund-2 received 6 lakh shares, while Kelas Cohesion MK Best Ideas Sub-Trust was allotted 8.79 lakh shares.

Aug 09, 2024 / 05:30AM GMTOperator Ladies and gentlemen, good day, and welcome to the Shilpa Medicare earnings call. (Operator Instructions) Please note that th

Landmark Prop, Rail Vikas Nigam, Shilpa Medicare, Marksans Pharma and Ahluwalia Contracts, hit their fresh 52-week highs during the day.

The Nifty Bank index closed 0.83 per cent down at 52660.35.

The Nifty IT index was trading 0.14 per cent down at 37674.05.

The Nifty Pharma index was trading 0.66 per cent up at 20325.3.

BSE Sensex and Nifty 50 trade higher; sectoral indices show mixed trends; stock updates and market analysis.

Stay abreast of latest news about Indian stock markets here on April 18. Most share indices in the Asia-Pacific were trading higher as investors look forward to earnings of big tech firms. Brent crude was trading 0.07% higher at $87.36 a barrel. Gold rose 0.37% to $2,369.67 an ounce.

Stocks to watch: Check out the companies making headlines before the opening bell today, on April 9, 2024.

Piramal Alternatives Trust acquires stake in Annapurna Finance, Bajaj Auto's Vice Chairman resigns, Magma Ventures sells shares of Poonawalla Fincorp, SBI Cards raises funds, CCEA approves coal-to-SNG project, Shilpa Medicare ordered to pay damages, Sarda Metals approves new project, Dhanuka Agritech signs Letter of Intent, Auro Laboratories acquires leasehold land, Catvision sells land & building, Gainwell Group acquires stake in TIL, Mastek collaborates with Microsoft, Kamat Hotels signs JDA, Tamil Nadu Transmission terminates contract, Borosil to raise funds through QIP.

Stocks to watch: Check out the companies making headlines before the opening bell today, on November 3, 2023.